Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...
For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2017 ...
In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, to explain how ...
image: 68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease. (A) Patient with high 68Ga-ABY-025 ...
Role of PET/CT in prognosticating post-transplant outcomes based on a new scoring system: Results of PIPET-M TRIAL. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone ...
Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback